Filtered By:
Specialty: Cancer & Oncology

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 61 results found since Jan 2013.

Homeopathy effects in patients during oncological treatment: a systematic review
CONCLUSIONS: For homeopathy, there is neither a scientifically based hypothesis of its mode of action nor conclusive evidence from clinical studies in cancer care.PMID:35731274 | DOI:10.1007/s00432-022-04054-6
Source: Clinical Genitourinary Cancer - June 22, 2022 Category: Cancer & Oncology Authors: Anna Wagenknecht Jennifer D örfler Maren Freuding Lena Josfeld Jutta Huebner Source Type: research

Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors
CONCLUSIONS: Uptake of recommendations to improve CRF, including adequate PA and use of psychosocial services, seemed suboptimal among patients with early-stage BC, whereas there was a nonnegligible interest in homeopathy and naturopathy. Findings of this large study indicate the need to implement recommendations for managing CRF in clinical practice.PMID:35130491 | DOI:10.6004/jnccn.2021.7051
Source: Journal of the National Comprehensive Cancer Network : JNCCN - February 7, 2022 Category: Cancer & Oncology Authors: Antonio Di Meglio Cecile Charles Elise Martin Julie Havas Arnauld Gbenou Jean-Daniel Flaysakier Anne-Laure Martin Sibille Everhard Enora Laas Nicolas Chopin Laurence Vanlemmens Christelle Jouannaud Christelle Levy Olivier Rigal Marion Fournier Patrick Sou Source Type: research

Cancer-Related Fatigue —Is There a Role for Complementary and Integrative Medicine?
AbstractPurpose of ReviewThis review aims to assess recent data on possible effective and safe complementary and integrative medicine (CIM) modalities that can be of help to patients affected by cancer that suffer from cancer-related fatigue (CRF).Recent FindingsCancer-related fatigue (CRF) is one of the most common, persistent, and challenging symptoms among cancer patients and survivors. Many world-leading cancer centers incorporate CIM into routine cancer care including integrating multiple approaches to address CRF. Approaches that are supported by clinical evidence on the use of CIM during and following conventional o...
Source: Current Oncology Reports - November 7, 2021 Category: Cancer & Oncology Source Type: research

Determinants of use of oral complementary-alternative medicine among women with early breast cancer:  a focus on cancer-related fatigue
ConclusionOne-in-four patients reported use of OCAM. More severe CRF was consistently associated with its use. Moreover, older, better educated, wealthier, more anxious women, and those receiving chemotherapy seemed more prone to use OCAM. Characterizing profiles of BC patients more frequently resorting to OCAM may help deliver targeted information about its benefits and potential risks.
Source: Breast Cancer Research and Treatment - September 24, 2021 Category: Cancer & Oncology Source Type: research

Perceptions of homeopathy in supportive cancer care among oncologists and general practitioners in France
ConclusionsHomeopathy is viewed favorably as an integrated SCO therapy by the majority of French physicians involved with cancer patients —oncologists and GPs. Symptoms of particular relevance include fatigue, anxiety, peripheral neuropathy, sleep disturbance, and hot flashes. In such clinical situations, response to conventional therapies may be suboptimal and homeopathy is considered a reliable therapeutic option. These two studie s highlight the fact that homeopathy has gained legitimacy as the first complementary therapy in SCO in France.
Source: Supportive Care in Cancer - September 1, 2021 Category: Cancer & Oncology Source Type: research

Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center
Conclusions: This study shows that CAM use is frequent among adults and pediatric patients with bone and soft tissue sarcoma as in other cancer patients. Moreover, the profile of these Italian CAM consumers in sarcoma patients is similar to other studies. Patients disclosure to their oncologist or physician about the use of CAM was similar to other Italian studies, but higher compared to other international studies.
Source: Journal of Cancer Research and Therapeutics - June 11, 2021 Category: Cancer & Oncology Authors: Alessandra Longhi Elisabetta Setola Cristina Ferrari Elisa Carretta Source Type: research